8-KFiled Aug 12, 8:00 PM ET

Rocket Lab Corp Announces Proposed Acquisition of Iridium

$RKLB · Rocket Lab Corp

Research Summary

AI-generated summary of this SEC filing

Updated

Rocket Lab Corp Announces Proposed Acquisition of Iridium

What Happened
Rocket Lab Corporation (RKLB) filed an 8-K on Aug 13, 2026 confirming the previously disclosed Agreement and Plan of Merger dated June 28, 2026 to combine with Iridium Communications Inc. Under the agreement, Merger Sub I will first merge into Iridium, with Iridium surviving as an indirect Rocket Lab subsidiary, and then the surviving company will merge into Merger Sub II (the two-step Transaction). The 8-K primarily furnishes Iridium’s financial information and KPMG LLP’s consent so those materials can be incorporated by reference into Rocket Lab’s Registration Statement on Form S-4.

Key Details

  • Merger Agreement dated June 28, 2026 between Rocket Lab and Iridium; 8-K filed Aug 13, 2026.
  • Iridium audited consolidated financials for years ended Dec 31, 2025 and 2024 (from Iridium’s 2025 Form 10-K) and unaudited Q2 2026 results (Form 10-Q) were incorporated by reference.
  • Rocket Lab filed unaudited pro forma condensed combined financial statements (as of June 30, 2026 and for specified periods) as Exhibit 99.3 to the 8-K.
  • KPMG LLP provided a consent (Exhibit 23.1) allowing Iridium’s financial information to be incorporated by reference into Rocket Lab’s Form S-4; the Form S-4 (proxy statement/prospectus) has been filed but is not yet effective.

Why It Matters
This 8-K confirms a pending, material merger that would bring Iridium’s satellite communications business into Rocket Lab’s corporate family. Rocket Lab provided audited and pro forma financial statements so investors can evaluate the transaction’s historical financials and the combined company on a pro forma basis. The deal remains subject to stockholder and regulatory approvals and other closing conditions; the Form S-4 must become effective before related Rocket Lab shares referenced in the proxy/prospectus can be sold. Investors should read the Form S-4/proxy statement/prospectus and the incorporated Iridium financial reports for full details and risks.